Short communication · 30 Dec 2022
Research articlePublished 1 Oct 2015
IN -VIVO ANTI-TUMOUR ACTIVITY OF NOVEL IMIDAZO-[2,1 B]-1,3,4-THIADIAZOLE DERIVATIVES IN EHRLICH ASCITES CARCINOMA AND DALTON?S LYMPHOMA AS CITIES MODEL
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objective: To study the In-vivo antitumor activity of Novel Imidazo[2,1b]-1,3,4-thiadiazole derivatives on Ehrlich Ascites Carcinoma (EAC) and Dalton Ascites Lymphoma model.(DLA). Materials and Metho ds: The two novel imidazothiadiazole analogues ( Compound 4b, NSC:760239 and Compound 4c, NSC: 760240), in three different concentration were evaluated for their antitumor activity against Ehrlich Ascites Carcinoma (EAC) and two different concentrations were evaluated against Dalton’s ascites lymphoma (DLA), models. In EAC model increase in mean survival time of the drug was measured against control and standard (Levamisole) in mice. Their toxicity was assessed in normal, standard, and EAC bearing mice by measuring the drug induced changes in haematological parameters, In DLA model, the solid tumor volume, solid tumor weight, and % inhibition of the tumor weight of the drug treated over control and standard mice was measured. It is concluded that both the compounds showed dose dependent anticancer activity against control and standard Results: Both the molecules 4b and 4c showed dose dependent anticancer activity against control and standard. The compound 4b was more effective when compared to compound 4c mainly. Conclusion: from the observed results the compound 4b was more effective when compared to compound 4c.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Harmonized Research in Pharmacy.
Opinion · 30 Dec 2022
CLINICAL IMPORTANCE OF GERIATRIC DISORDERS DURING ACUTE HOSPITALIZATION
Commentary · 30 Dec 2022
APPLICATIONS OF ORGANIC AND PHARMACEUTICAL COMPOUNDS
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Harmonized Research in Pharmacy
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Pallavi K.J.”
- BylineArticles whose byline prints “S.V. Satyanarayana”
- BylineArticles whose byline prints “B.S. Tippeswamy”
